Jim Simons's position in Cytosorbents is currently worth $76.7 Thousand. That's 0.00% of their equity portfolio (2912th largest holding). The first Cytosorbents trade was made in Q2 2018. Since then Jim Simons bought shares twelve more times and sold shares on nine occasions. The investor's estimated purchase price is $212 Thousand, resulting in a loss of 64%.